Mechanism of Action
E. coli Nissle 1917 (EcN) is a non-pathogenic strain of E. coli that lacks virulence genes but retains superior competitive machinery (Primitive 8: Siderophore Competition and Iron Ecology).
EcN outcompetes the key pathogenic taxa in the endometriosis signature through two primary mechanisms pendergrass 2026 endometriosis conference:
Superior siderophore systems: EcN has more sensitive siderophores and better iron acquisition systems than pathogenic strains. In the iron-rich, siderophore-competitive environment of endometriosis, EcN wins the iron war.
Nickel uptake: EcN also uptakes nickel, depleting the cofactor that pathogenic strains need for glyoxalase (immune evasion), urease (pH disruption), and hydrogenase (hypoxia).
Hypoxic competition: Unlike many probiotics, EcN competes even in hypoxic environments — critical given that hypoxia is a defining ecological feature of the endometriosis microenvironment.
Breadth of competitive exclusion: EcN outcompetes pathogenic E. coli, B. fragilis, Group B Strep, F. nucleatum, C. albicans, K. pneumoniae, and S. typhimurium — covering nearly all enriched taxa in the endometriosis signature pendergrass 2026 endometriosis conference.
Triangle Evidence
Condition: [[endometriosis]]
I → f (EcN displaces signature pathogens):
Strong evidence that EcN outcompetes each of the enriched pathogenic taxa through superior siderophore and nickel acquisition. This is the two-sided ecological engineering approach — suppress pathogens while occupying the niche.
I → D (EcN benefits endometriosis patients):
EcN is an established probiotic with demonstrated ability to displace the specific pathogenic community driving endometriosis.
f → D (Displaced taxa drive endometriosis):
The taxa outcompeted by EcN are responsible for estrogen recirculation (beta-glucuronidase), hypoxia (hydrogenase), immune evasion (glyoxalase), and tissue degradation (metalloprotease) — all core features of endometriosis.
Status: Validated
Note
E. coli Nissle 1917 is sometimes genetically modified. The non-modified strain is preferred for this application. Available commercially as Mutaflor in some markets.